Efficacy and Safety of Turoctocog Alfa Pegol (N8-GP) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A (pathfinder10)
Clinical trial NCT05082116 · COMPLETED
Trial details
- NCT number
- NCT05082116
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-27
- Primary completion
- 2022-12-28
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.